We describe a simplIfied electroimmunoassay for quantification of human apolipoproteins A-I and B on prepared plates. A solution of agarose at 55 #{176}C, containing hydroxyethyicellulose and antibodies,Is pouredonto a plastic film and allowed to gel. Wells are punched in the gels and the plates are dried for storage. Before use, they are rehy&ated and buffered. We use succinylated Sudan Black to prestain lipoprotein fractions of plasma. After electrophoresing samples of plasma or standards for 3 h at 4#{176}C at 12.5 V/cm, we measure the peak heights and read the results from a standardcurve prepared by usingcalibrated sera of known apolipoprotein B and A-I content as secondary standard. The within-and between-assay coeff idents of variation were <4% in all cases. Results correlated Well with those obtained by classic electroimmunodiffusion. Subjects with confIrmed atherosclerotic lesions had significantly (p <1O-) lower ratios of apolipoprotein A-I to apolipoprotein B, compared with ratios in controls.
and enzyme immunoassay (12) .
In this report we describe a simple yet precise and accurate electroimmunodiffusion assay involving use of commercially prepared plates for simultaneous determination of human Apo A-I and B.
Materials and Methods
Blood was drawn after an overnight fast, allowed to clot at room temperature for 60 mm, and the serum was separated by low-speed centrifugation.
Patients were men and women, ages 20 to 70 years, who were undergoing coronary angiography at the Cardiologic Hospital (Prof. Bertrand), Lille, France. Its purity was assessed by polyacrylamide gel electrophoresis in sodium dodecyl sulfate (19) and by immunodiffusion techniques with specific antisera. Antisera. Antisera to Ape B and to Ape A-I were prepared in adult female goats or rabbits. We emulsified 1 to 10mg of antigens with an equal volume of Freund's complete adjuvant and injected the emulsion according to Vaitukaitis et aL (20) . After six weeks, a second injection was administered. The animals were bled two weeks later. The specificity of the antisera was assessed by double immunodiffusion and twodimensional immunoelectrophoresis.
Survivors

Plates for electrophoresis (Apofllms Al and B
). An 8 g/L solution of agarose at 55#{176}C containing 12 g of hydroxyethylcellulose per liter, and antisera at a suitable dilution, was poured onto plastic films' and allowed to gel at room temperature. Wells, 30 per film, were punched in the gel and the plates were dried. Before use, they were rehydrated for 30 mm with distilled water and buffered with phosphate buffer1 (pH 9.2). They should be stored for no longer than 24 h at +4#{176}C before use.
Elect roimmunoassay
of apo B and apo A-I. For prestaining lipoproteins from sera or standards, we used succinylated Sudan Black (equal volumes of Sudan Black solution,1 and 0.1 mol/L saline). We then placed 2 iL of this mixture into each well and electrophoresed for 3 h at 4 #{176}C with a field strength of 12.5 V/cm. Immunoprecipitates ("rockets") corresponding to Apo B (low peaks) and Ape A-I (high peaks) were then visible (Figure 1) .
The height of each rocket was measured from the center of the antigen well to the apex of the peak. The plates were then soaked 1 h in distilled water and dried at room temperature. We included in each run three dilutions of a standard of of plates gave a single peak on crossed immunoelectrophoresis against whole human, showing that it was directed against a single antigen.
Accuracy.
We have compared results obtained by the proposed method with those given by classic electroimmunodiffusion (22), generally accepted as a reference-quality method, for 100 different samples from patients, selected to include a wide range of apolipoprotein concentrations. Results by the two methods correlated well and the means were closely similar (Table 1) .
Clinical value in coronary artery disease. Lipid and apoprotein concentrations were determined in normal controls (group I, n = 146) and in patients with (group II, n = 141) and without (group III, n = 102) coronary artery disease demonstrable by coronary angiography. All subjects were chosen without conscious bias. The results are given in Table 2 . Patients with coronary artery disease had increased concentrations of lipids and ape B, decreased concentrations of ape A-I, and a decreased ratio of Ape A-I/Ape B. The diagnostic value of each of these variables was then studied for its ability to differentiate between group land group II (Figure 3 Figure 2 shows the relationship between rocket heights and Apo B and A-I content of the standards.
Reproducibility.
Within-run 
Discussion
Although large-scale epidemiological studies (23, 24) have focused attention on the association between above-normal concentrations of plasma lipids and coronary heart disease, quantitative apelipeprotein determination may be a more nearly accurate predictor in the recognition of risk factors for atherosclerosis. Our own efforts in this field have been directed towards the development of simple and precise immunological methods for quantitation of the two major apeproteins, Ape A-I and Apo B, with the main objective of enabling reliable measurements under routine laboratory conditions. This electroimmunoassay for Ape B and A-I with use of prepared plates is very reproducible, inexpensive, and easy to perform. Furthermore, it requires no prior extraction of lipids, no staining and destaining of the gels, and only 20 pL of plasma. It seems well adapted in clinical practice for population screening.
We applied this method to the analysis of plasma of patients with and without coronary artery disease as shown by coronary angiography. Our results suggest that determinations of Ape B or of the ratio of Ape A-I to Apo B are better indexes than lipid measurement for the evaluation of atherosclerosis. Although this study was not a prospective one, in our opinion these data show the usefulness of an accurate and precise method for quantification of plasma apelipeproteins for assessing the risk of coronary artery disease in a single patient. This study, which at present is being continued and extended, also supports the close connection between plasma lipeproteins and atherosclerosis. This work was supported by grant no. 80.30.23 from INSERM.
